Entry to the list of donations to the Foundation transparent account

Controling type 2 diabetes

Starlix (nateglinide)
0

Starlix (nateglinide)

October 30th, 2015 | by h4uclinic
Starlix (nateglinide) is an oral diabetes medicine that helps control blood sugar levels. This medicine helps your body respond better to insulin produced by your pancreas. Starlix is used together with diet and exercise to treat
Prandin (Repaglinide)
0

Prandin (Repaglinide)

October 30th, 2015 | by Great Britain Association
Prandin helps to keep down post meal blood glucose levels Prandin is a drug which is taken before meals and acts quickly to help keep blood glucose levels from rising too high after meals. The drug belongs to a group of diabetes
Funding the Next Generation of Brilliant Researchers
0

Funding the Next Generation of Brilliant Researchers

October 30th, 2015 | by American Association
Funding the Next Generation of Brilliant Researchers With nearly 30 million adults and children in the U.S. living with diabetes, and another 86 million living with prediabetes, diabetes is a physical and financial burden for the
How Grant Money is Divided
0

How Grant Money is Divided

October 30th, 2015 | by American Association
What kind of research does the American Diabetes Association support? Since the American Diabetes Association launched its Research Programs in 1952, it has invested more than $700 million in nearly 4,500 diabetes research
Research Excellence Honorees
0

Research Excellence Honorees

October 30th, 2015 | by American Association
Read about the inspiring individuals who have been recognized for excellence and innovation in diabetes research. Thomas R. Lee Career Developoment Award The American Diabetes Association established the Thomas R. Lee Career
Identifying Type 1 Diabetes before Beta Cell Loss
0

Identifying Type 1 Diabetes before Beta Cell Loss

October 30th, 2015 | by American Association
Martin Hessner, PhD | Medical College of Wisconsin |Basic Science Award | Funded for 3 years at $345,000 Type 1 diabetes is thought to progress without symptoms for several years in most patients prior to diagnosis. During this
Targeting the Autoimmune Response to Prevent Type 1 Diabetes
0

Targeting the Autoimmune Response to Prevent Type 1 Diabetes

October 30th, 2015 | by American Association
Jon Piganelli, PhD | University of Pittsburgh |Basic Science Award | Funded for 3 years at $345,000 Supported by The Order of the Amaranth Diabetes Foundation Type 1 diabetes develops following an autoimmune process that leads to
Regenerating Human Beta Cells
0

Regenerating Human Beta Cells

October 30th, 2015 | by American Association
Nathalie Fiaschi-Taesch, PhD |Icahn School of Medicine at Mount Sinai | Basic Science Award |Funded for 3 years at $345,000 Both type 1 and type 2 diabetes result from a complete or partial loss of beta cell number and function.
Type 1 Research Highlights
0

Type 1 Research Highlights

October 29th, 2015 | by American Association
While the Association’s priority is to improve the lives of all people affected by diabetes, type 1 diabetes is a critical focus of the organization. More than one-third of our research portfolio is dedicated to projects
We Support Your Doctor
0

We Support Your Doctor

October 28th, 2015 | by American Association
The Association’s Professional membership provides physicians, nurses, diabetes educators and other health professionals with the most current information about breakthroughs in diabetes research and treatment options. They